{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:29:29Z","timestamp":1793312969264,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41418-026-01665-1","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:42:58Z","timestamp":1769697778000},"page":"1455-1473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and stabilizing BAG3"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9936-4516","authenticated-orcid":false,"given":"Yongkang","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9744-7201","authenticated-orcid":false,"given":"Jun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8596-9387","authenticated-orcid":false,"given":"Shutao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-8043","authenticated-orcid":false,"given":"Chunle","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangwei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5664-7757","authenticated-orcid":false,"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1654-1285","authenticated-orcid":false,"given":"Renyi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"1665_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"1665_CR2","doi-asserted-by":"publisher","first-page":"e073995","DOI":"10.1136\/bmj-2022-073995","volume":"383","author":"M Del Chiaro","year":"2023","unstructured":"Del Chiaro M, Sugawara T, Karam SD, Messersmith WA. Advances in the management of pancreatic cancer. BMJ. 2023;383:e073995.","journal-title":"BMJ"},{"key":"1665_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"1665_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326:851\u201362.","journal-title":"JAMA"},{"key":"1665_CR5","doi-asserted-by":"crossref","unstructured":"Chakrabarti S, Kamgar M, Mahipal A. Systemic therapy of metastatic pancreatic adenocarcinoma: current status, challenges, and opportunities. Cancers. 2022;14:2588.","DOI":"10.3390\/cancers14112588"},{"key":"1665_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","volume":"16","author":"O Strobel","year":"2019","unstructured":"Strobel O, Neoptolemos J, Jager D, Buchler MW. Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol. 2019;16:11\u201326.","journal-title":"Nat Rev Clin Oncol"},{"key":"1665_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nsmb.1842","volume":"17","author":"YL Deribe","year":"2010","unstructured":"Deribe YL, Pawson T, Dikic I. Post-translational modifications in signal integration. Nat Struct Mol Biol. 2010;17:666\u201372.","journal-title":"Nat Struct Mol Biol"},{"key":"1665_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","volume":"45","author":"J Liu","year":"2016","unstructured":"Liu J, Qian C, Cao X. Post-translational modification control of innate immunity. Immunity. 2016;45:15\u201330.","journal-title":"Immunity"},{"key":"1665_CR9","doi-asserted-by":"crossref","unstructured":"Antao AM, Tyagi A, Kim KS, Ramakrishna S. Advances in deubiquitinating enzyme inhibition and applications in cancer therapeutics. Cancers. 2020;12:1579.","DOI":"10.3390\/cancers12061579"},{"key":"1665_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.molcel.2009.01.014","volume":"33","author":"ZJ Chen","year":"2009","unstructured":"Chen ZJ, Sun LJ. Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell. 2009;33:275\u201386.","journal-title":"Mol Cell"},{"key":"1665_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"1665_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29684-9","volume":"13","author":"JK Nelson","year":"2022","unstructured":"Nelson JK, Thin MZ, Evan T, Howell S, Wu M, Almeida B, et al. USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Nat Commun. 2022;13:2070.","journal-title":"Nat Commun"},{"key":"1665_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41418-022-01102-z","volume":"30","author":"H Yang","year":"2023","unstructured":"Yang H, Zhang X, Lao M, Sun K, He L, Xu J, et al. Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell Death Differ. 2023;30:560\u201375.","journal-title":"Cell Death Differ"},{"key":"1665_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1083\/jcb.200401141","volume":"166","author":"J McCullough","year":"2004","unstructured":"McCullough J, Clague MJ, Urbe S. AMSH is an endosome-associated ubiquitin isopeptidase. J Cell Biol. 2004;166:487\u201392.","journal-title":"J Cell Biol"},{"key":"1665_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cub.2005.11.073","volume":"16","author":"J McCullough","year":"2006","unstructured":"McCullough J, Row PE, Lorenzo O, Doherty M, Beynon R, Clague MJ, et al. Activation of the endosome-associated ubiquitin isopeptidase AMSH by STAM, a component of the multivesicular body-sorting machinery. Curr Biol. 2006;16:160\u20135.","journal-title":"Curr Biol"},{"key":"1665_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/ng.2602","volume":"45","author":"LM McDonell","year":"2013","unstructured":"McDonell LM, Mirzaa GM, Alcantara D, Schwartzentruber J, Carter MT, Lee LJ, et al. Mutations in STAMBP, encoding a deubiquitinating enzyme, cause microcephaly-capillary malformation syndrome. Nat Genet. 2013;45:556\u201362.","journal-title":"Nat Genet"},{"key":"1665_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15203","volume":"8","author":"JS Bednash","year":"2017","unstructured":"Bednash JS, Weathington N, Londino J, Rojas M, Gulick DL, Fort R, et al. Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity. Nat Commun. 2017;8:15203.","journal-title":"Nat Commun"},{"key":"1665_CR18","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s12276-022-00890-1","volume":"54","author":"Q Yang","year":"2022","unstructured":"Yang Q, Yan D, Zou C, Xue Q, Lin S, Huang Q, et al. The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability. Exp Mol Med. 2022;54:2047\u201359.","journal-title":"Exp Mol Med"},{"key":"1665_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.bbrc.2018.11.068","volume":"507","author":"Y Iwakami","year":"2018","unstructured":"Iwakami Y, Yokoyama S, Watanabe K, Hayakawa Y. STAM-binding protein regulates melanoma metastasis through SLUG stabilization. Biochem Biophys Res Commun. 2018;507:484\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1665_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.neo.2021.05.011","volume":"23","author":"H Xu","year":"2021","unstructured":"Xu H, Yang X, Xuan X, Wu D, Zhang J, Xu X, et al. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR\/MAPK signaling pathway. Neoplasia. 2021;23:607\u201323.","journal-title":"Neoplasia"},{"key":"1665_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07048-z","volume":"15","author":"W Zhang","year":"2024","unstructured":"Zhang W, Xu Z, Du Y, Liu T, Xiong Z, Hu J, et al. Identification of STAM-binding protein as a target for the treatment of gemcitabine-resistant pancreatic cancer in a nutrient-poor microenvironment. Cell Death Dis. 2024;15:657.","journal-title":"Cell Death Dis"},{"key":"1665_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.tips.2016.04.007","volume":"37","author":"C Behl","year":"2016","unstructured":"Behl C. Breaking BAG: the Co-Chaperone BAG3 in health and disease. Trends Pharmacol Sci. 2016;37:672\u201388.","journal-title":"Trends Pharmacol Sci"},{"key":"1665_CR23","doi-asserted-by":"crossref","unstructured":"Kirk JA, Cheung JY, Feldman AM. Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease. J Clin Investig. 2021;131:e149415.","DOI":"10.1172\/JCI149415"},{"key":"1665_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4161\/auto.5407","volume":"4","author":"S Carra","year":"2008","unstructured":"Carra S, Seguin SJ, Landry J. HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy. Autophagy. 2008;4:237\u20139.","journal-title":"Autophagy"},{"key":"1665_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.24","volume":"2","author":"A Rosati","year":"2011","unstructured":"Rosati A, Graziano V, De Laurenzi V, Pascale M, Turco MC. BAG3: a multifaceted protein that regulates major cell pathways. Cell Death Dis. 2011;2:e141.","journal-title":"Cell Death Dis"},{"key":"1665_CR26","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1083\/jcb.201701064","volume":"216","author":"MX An","year":"2017","unstructured":"An MX, Li S, Yao HB, Li C, Wang JM, Sun J, et al. BAG3 directly stabilizes Hexokinase 2 mRNA and promotes aerobic glycolysis in pancreatic cancer cells. J Cell Biol. 2017;216:4091\u2013105.","journal-title":"J Cell Biol"},{"key":"1665_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217005","volume":"597","author":"J Liu","year":"2024","unstructured":"Liu J, Zhai M, Chen Y, Wei Y, Li F, Chen Y, et al. Acetylation-dependent deubiquitinase USP26 stabilizes BAG3 to promote breast cancer progression. Cancer Lett. 2024;597:217005.","journal-title":"Cancer Lett"},{"key":"1665_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-024-00528-z","volume":"13","author":"S Li","year":"2024","unstructured":"Li S, Yang L, Ding X, Sun H, Dong X, Yang F, et al. USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway. Oncogenesis. 2024;13:27.","journal-title":"Oncogenesis"},{"key":"1665_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011;17:500\u20133.","journal-title":"Nat Med"},{"key":"1665_CR30","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/gutjnl-2018-317163","volume":"69","author":"C Liang","year":"2020","unstructured":"Liang C, Shi S, Qin Y, Meng Q, Hua J, Hu Q, et al. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer. Gut. 2020;69:888\u2013900.","journal-title":"Gut"},{"key":"1665_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3892\/ijo.2016.3494","volume":"49","author":"S Habata","year":"2016","unstructured":"Habata S, Iwasaki M, Sugio A, Suzuki M, Tamate M, Satohisa S, et al. BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer. Int J Oncol. 2016;49:402\u201310.","journal-title":"Int J Oncol"},{"key":"1665_CR32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ygyno.2014.06.024","volume":"134","author":"A Sugio","year":"2014","unstructured":"Sugio A, Iwasaki M, Habata S, Mariya T, Suzuki M, Osogami H, et al. BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer. Gynecol Oncol. 2014;134:615\u201323.","journal-title":"Gynecol Oncol"},{"key":"1665_CR33","doi-asserted-by":"publisher","first-page":"28490","DOI":"10.1074\/jbc.M209682200","volume":"278","author":"H Doong","year":"2003","unstructured":"Doong H, Rizzo K, Fang S, Kulpa V, Weissman AM, Kohn EC. CAIR-1\/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins. J Biol Chem. 2003;278:28490\u2013500.","journal-title":"J Biol Chem"},{"key":"1665_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41420-022-00817-9","volume":"8","author":"M De Marco","year":"2022","unstructured":"De Marco M, Gauttier V, Pengam S, Mary C, Ranieri B, Basile A, et al. Concerted BAG3 and SIRPalpha blockade impairs pancreatic tumour growth. Cell Death Discov. 2022;8:94.","journal-title":"Cell Death Discov"},{"key":"1665_CR35","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1074\/jbc.M209677200","volume":"278","author":"JR Burke","year":"2003","unstructured":"Burke JR, Pattoli MA, Gregor KR, Brassil PJ, MacMaster JF, McIntyre KW, et al. BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem. 2003;278:1450\u20136.","journal-title":"J Biol Chem"},{"key":"1665_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.tcb.2020.12.003","volume":"31","author":"RJ Antonia","year":"2021","unstructured":"Antonia RJ, Hagan RS, Baldwin AS. Expanding the View of IKK: New Substrates and New Biology. Trends Cell Biol. 2021;31:166\u201378.","journal-title":"Trends Cell Biol"},{"key":"1665_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2015.11.031","volume":"371","author":"K Wu","year":"2016","unstructured":"Wu K, Yang Y, Zhao J, Zhao S. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10. Cancer Lett. 2016;371:125\u201333.","journal-title":"Cancer Lett"},{"key":"1665_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3892\/or.2017.5706","volume":"38","author":"S Qiu","year":"2017","unstructured":"Qiu S, Sun L, Jin Y, An Q, Weng C, Zheng J. Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy. Oncol Rep. 2017;38:309\u201316.","journal-title":"Oncol Rep"},{"key":"1665_CR39","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.7150\/thno.69424","volume":"12","author":"C Zhang","year":"2022","unstructured":"Zhang C, Xu C, Gao X, Yao Q. Platinum-based drugs for cancer therapy and anti-tumour strategies. Theranostics. 2022;12:2115\u201332.","journal-title":"Theranostics"},{"key":"1665_CR40","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/S0140-6736(23)01366-1","volume":"402","author":"ZA Wainberg","year":"2023","unstructured":"Wainberg ZA, Melisi D, Macarulla T, Pazo Cid R, Chandana SR, De La Fouchardiere C, et al. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial. Lancet. 2023;402:1272\u201381.","journal-title":"Lancet"},{"key":"1665_CR41","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817\u201325.","journal-title":"N Engl J Med"},{"key":"1665_CR42","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"1665_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15:333\u201348.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1665_CR44","doi-asserted-by":"publisher","first-page":"15722","DOI":"10.1073\/pnas.1308014110","volume":"110","author":"F Huang","year":"2013","unstructured":"Huang F, Zeng X, Kim W, Balasubramani M, Fortian A, Gygi SP, et al. Lysine 63-linked polyubiquitination is required for EGF receptor degradation. Proc Natl Acad Sci USA. 2013;110:15722\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1665_CR45","doi-asserted-by":"publisher","first-page":"13990","DOI":"10.1074\/jbc.M109.061309","volume":"285","author":"MI Sierra","year":"2010","unstructured":"Sierra MI, Wright MH, Nash PD. AMSH interacts with ESCRT-0 to regulate the stability and trafficking of CXCR4. J Biol Chem. 2010;285:13990\u20134004.","journal-title":"J Biol Chem"},{"key":"1665_CR46","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1096\/fj.13-248963","volume":"28","author":"TM Ribeiro-Rodrigues","year":"2014","unstructured":"Ribeiro-Rodrigues TM, Catarino S, Marques C, Ferreira JV, Martins-Marques T, Pereira P, et al. AMSH-mediated deubiquitination of Cx43 regulates internalization and degradation of gap junctions. FASEB J. 2014;28:4629\u201341.","journal-title":"FASEB J"},{"key":"1665_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41589-024-01683-5","volume":"21","author":"Z Peng","year":"2025","unstructured":"Peng Z, Fang W, Wu B, He M, Li S, Wei J, et al. Targeting Smurf1 to block PDK1-Akt signaling in KRAS-mutated colorectal cancer. Nat Chem Biol. 2025;21:59\u201370.","journal-title":"Nat Chem Biol"},{"key":"1665_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"Fresno Vara","year":"2004","unstructured":"Vara Fresno, Casado JA, de Castro E, Cejas J, Belda-Iniesta P, Gonzalez-Baron C. M. PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30:193\u2013204.","journal-title":"Cancer Treat Rev"},{"key":"1665_CR49","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1038\/sj.onc.1203797","volume":"19","author":"H Doong","year":"2000","unstructured":"Doong H, Price J, Kim YS, Gasbarre C, Probst J, Liotta LA, et al. CAIR-1\/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70\/Hsc70. Oncogene. 2000;19:4385\u201395.","journal-title":"Oncogene"},{"key":"1665_CR50","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1038\/onc.2012.466","volume":"32","author":"N Li","year":"2013","unstructured":"Li N, Du ZX, Zong ZH, Liu BQ, Li C, Zhang Q, et al. PKCdelta-mediated phosphorylation of BAG3 at Ser187 site induces epithelial-mesenchymal transition and enhances invasiveness in thyroid cancer FRO cells. Oncogene. 2013;32:4539\u201348.","journal-title":"Oncogene"},{"key":"1665_CR51","first-page":"4173","volume":"126","author":"Z Xu","year":"2013","unstructured":"Xu Z, Graham K, Foote M, Liang F, Rizkallah R, Hurt M, et al. 14-3-3 protein targets misfolded chaperone-associated proteins to aggresomes. J Cell Sci. 2013;126:4173\u201386.","journal-title":"J Cell Sci"},{"key":"1665_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102238","volume":"50","author":"N Zhang","year":"2022","unstructured":"Zhang N, Zhang Y, Miao W, Shi C, Chen Z, Wu B, et al. An unexpected role for BAG3 in regulating PARP1 ubiquitination in oxidative stress-related endothelial damage. Redox Biol. 2022;50:102238.","journal-title":"Redox Biol"},{"key":"1665_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-021-00827-7","volume":"29","author":"P Liu","year":"2022","unstructured":"Liu P, Cong X, Liao S, Jia X, Wang X, Dai W, et al. Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumourigenesis. Cell Death Differ. 2022;29:1\u201313.","journal-title":"Cell Death Differ"},{"key":"1665_CR54","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1093\/emboj\/20.15.4132","volume":"20","author":"F Itoh","year":"2001","unstructured":"Itoh F, Asao H, Sugamura K, Heldin CH, ten Dijke P, Itoh S. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J. 2001;20:4132\u201342.","journal-title":"EMBO J"},{"key":"1665_CR55","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691\u2013703.","journal-title":"N Engl J Med"},{"key":"1665_CR56","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1002\/cncr.35479","volume":"130","author":"A Gupta","year":"2024","unstructured":"Gupta A, De Jesus-Acosta A, Le D, Pishvaian M, Zaidi N, Zheng L, et al. Clinical outcomes of liposomal irinotecan in patients with advanced pancreatic cancer previously treated with conventional irinotecan: a meta-analysis of real-world evidence. Cancer. 2024;130:3734\u201344.","journal-title":"Cancer"},{"key":"1665_CR57","first-page":"4244s","volume":"46","author":"KS McCarty Jr","year":"1986","unstructured":"McCarty KS Jr, Szabo E, Flowers JL, Cox EB, Leight GS, Miller L, et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumours. Cancer Res. 1986;46:4244s\u20138s.","journal-title":"Cancer Res"},{"key":"1665_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100398","volume":"37","author":"Z Wen","year":"2024","unstructured":"Wen Z, Luo D, Wang S, Rong R, Evers BM, Jia L, et al. Deep learning-based H-score quantification of immunohistochemistry-stained images. Mod Pathol. 2024;37:100398.","journal-title":"Mod Pathol"},{"key":"1665_CR59","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol Y, Bandla C, Kundu DJ, Kamatchinathan S, Bai J, Hewapathirana S, et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 2025;53:D543\u2013D53.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01665-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01665-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01665-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:02:48Z","timestamp":1783432968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01665-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1665"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01665-1","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal experiments were conducted in accordance with the guidelines set forth by the Association for Assessment and Accreditation of Laboratory Animal Care and approved by the Committee on Ethics of Animal Experiments of Huazhong University of Science and Technology (TJH-202109010). The collection of patient tissues was approved by the Ethics Committee of Tongji Hospital, Huazhong University of Science and Technology, and was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}